Profil
Marlon Braumann was the founder of Ames Foundation (2020), store2be GmbH (2015), and Elevat3 Capital Ltd. (2020) where he holds the titles of Managing Director and Managing Partner respectively.
Dr. Braumann is also the founder of Amyriad Therapeutics, Inc. Dr. Braumann's current jobs include being a Director at Gropyus AG since 2021 and a Board Member at Bullfinch Holding GmbH since 2021.
Dr. Braumann's former job was as a Member-Supervisory Board at SynBiotic SE from 2020 to 2023.
Dr. Braumann's education includes an undergraduate degree from WHU-Otto Beisheim School of Management (2011), a graduate degree from WHU-Otto Beisheim School of Management (2013), a doctorate degree from WHU-Otto Beisheim School of Management (2015), an undergraduate degree from University Carlos III of Madrid (2014), and an MBA degree from Robert H.
Smith School of Business (2013).
Postes actifs de Marlon Braumann
| Sociétés | Poste | Début |
|---|---|---|
Elevat3 Capital Ltd.
Elevat3 Capital Ltd. Investment ManagersFinance Elevat3 seeks investment opportunities in companies located in Europe. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements with an investment size ranging form USD 5 - 20 million. It also acts as a lead investor. | Fondateur | 01/01/2020 |
Ames Foundation
Ames Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Fondateur | 01/07/2020 |
Amyriad Therapeutics, Inc.
Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company intended to develop therapies for the relief of Alzheimer's disease symptoms | Fondateur | - |
Gropyus AG
Gropyus AG HomebuildingConsumer Durables Constructs homes | Directeur/Membre du Conseil | 01/11/2021 |
Bullfinch Holding GmbH
Bullfinch Holding GmbH Internet Software/ServicesTechnology Services Operates as a financial technology platform company | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Marlon Braumann
| Sociétés | Poste | Fin |
|---|---|---|
| SYNBIOTIC SE | Directeur/Membre du Conseil | 11/04/2023 |
store2be GmbH
store2be GmbH Internet Software/ServicesTechnology Services Provides live communication, offline marketing and advertising services | Directeur Général | - |
Formation de Marlon Braumann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
WHU-Otto Beisheim School of Management
WHU-Otto Beisheim School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University Carlos III of Madrid
University Carlos III of Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert H. Smith School of Business
Robert H. Smith School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
store2be GmbH
store2be GmbH Internet Software/ServicesTechnology Services Provides live communication, offline marketing and advertising services | Technology Services |
SynBiotic SE
SynBiotic SE Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Elevat3 Capital Ltd.
Elevat3 Capital Ltd. Investment ManagersFinance Elevat3 seeks investment opportunities in companies located in Europe. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements with an investment size ranging form USD 5 - 20 million. It also acts as a lead investor. | Finance |
Bullfinch Holding GmbH
Bullfinch Holding GmbH Internet Software/ServicesTechnology Services Operates as a financial technology platform company | Technology Services |
Ames Foundation
Ames Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Gropyus AG
Gropyus AG HomebuildingConsumer Durables Constructs homes | Consumer Durables |
Amyriad Therapeutics, Inc.
Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company intended to develop therapies for the relief of Alzheimer's disease symptoms | Health Technology |
















